Effectiveness of the Myofascial Therapy in the Hemophilic Arthropathy of Ankle

Real Fundación Victoria Eugenia65 enrolled

Overview

Randomized clinical trial to assess the efficacy of a treatment protocol applied fascial therapy in patients with hemophilic arthropathy ankle, oriented to know and describe the observed differences on the dependent variables: range of motion, pain and physical condition. At the same time, the study will determine whether there are adverse effects or bleeding complications as a result of applied physiotherapy treatment.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Haemophilia

Interventions

Physiotherapy sessionsOTHER

Physiotherapy by techniques myofascial therapy, in patients with ankle hemophilic arthropathy

Eligibility

Sex: MALEMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Patients diagnosed with hemophilia A and B * Adults patients * Patients with hemophilic arthropathy of ankle diagnosed * Patients in prophylactic treatment regimen or on demand treatment with concentrates of FVIII/FIX. Exclusion Criteria: * Patients without ambulation * Patients diagnosed with other congenital coagulopathy (eg, Von Willebrand disease) * Patients who have developed antibodies to FVIII / FIX (inhibitors) * Patients with neurological or cognitive impairments that prevent understanding of questionnaires and test physical * Patients that have not signed the informed consent document.

Outcomes

Primary Outcomes

Change from baseline bleeding frequency after treatment and at 5 months

Evaluation of the frequency of muscle and joint bleeds through registration. The frequency of bleeding of the ankle joint is measured with a registry given to patients at the beginning of the study.

Time frame: Screening visit, within the first seven days after treatment and after five months follow-up visit

Change from baseline joint pain of ankle after treatment and at 5 months

Change from joint pain of ankle during treatment and follow-up period at 5 months. The perception of ankle pain will be measured using visual analog scale (scale 0-10).

Time frame: Screening visit, within the first seven days after treatment and after five months follow-up visit

Change from baseline joint function after treatment and at 5 months

Change from joint health during treatment and follow-up period at 5 months. Measurement instrument: Haemophilia Joint Health Score (scale 0-20).

Time frame: Screening visit, within the first seven days after treatment and after five months follow-up visit

Change from baseline range of motion after treatment and at 5 months

Change from range of movement of ankle and knee during treatment and follow-up period at 5 months. The range of motion of the ankle joint will be measured using a universal goniometer, using the protocol for measuring joint motion described by Felipe Querol. Measurement instrument: universal goniometer with the protocol to measurement for patients with hemophilia

Time frame: Screening visit, within the first seven days after treatment and after five months follow-up visit

Secondary Outcomes

Age

Age of patients

Time frame: Screening visit

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.